UBS Group AG - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 99 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$289,000
-52.5%
12,100
-71.0%
0.00%
Q4 2020$609,000
+39.4%
41,709
+35.4%
0.00%
Q3 2020$437,000
-35.5%
30,807
-33.1%
0.00%
Q2 2020$677,000
+152.6%
46,043
-29.3%
0.00%
Q1 2020$268,000
-39.2%
65,085
-29.0%
0.00%
Q4 2019$441,000
+20.2%
91,677
+51.2%
0.00%
Q3 2019$367,000
+259.8%
60,633
+285.4%
0.00%
Q2 2019$102,000
+104.0%
15,731
+121.3%
0.00%
Q1 2019$50,000
-56.9%
7,110
-70.4%
0.00%
Q4 2018$116,000
-9.4%
24,004
+38.2%
0.00%
Q3 2018$128,000
+73.0%
17,368
+49.8%
0.00%
Q2 2018$74,000
+1380.0%
11,595
+1302.1%
0.00%
Q1 2018$5,000
-75.0%
827
-83.0%
0.00%
Q4 2017$20,000
-20.0%
4,856
+83.4%
0.00%
Q3 2017$25,000
-7.4%
2,648
+15.1%
0.00%
Q2 2017$27,000
-37.2%
2,300
-32.0%
0.00%
Q1 2017$43,000
-59.4%
3,380
-61.2%
0.00%
Q4 2016$106,000
+86.0%
8,707
+80.2%
0.00%
Q3 2016$57,000
-5.0%
4,831
-30.4%
0.00%
Q2 2016$60,000
+1400.0%
6,945
+892.1%
0.00%
Q1 2016$4,000
-50.0%
700
-35.5%
0.00%
Q4 2015$8,000
-92.0%
1,085
-91.5%
0.00%
Q3 2015$100,000
-50.2%
12,700
-42.8%
0.00%
Q2 2015$201,000
-26.9%
22,200
+4.7%
0.00%
Q1 2015$275,000
-16.2%
21,200
-12.2%
0.00%
Q4 2014$328,00024,1410.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders